All In MedTech

FDA Clearance Tracker · P010012-S160

ACUITY SPIRAL HEART FAILURE LEAD MODELS, 4591, 4592 AND 4593

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 16, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 16, 2008

Approved

Time to decision

220 days

Received Oct 9, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010012-S160
Device name
ACUITY SPIRAL HEART FAILURE LEAD MODELS, 4591, 4592 AND 4593
Applicant location
St Paul, MN
Received
Oct 9, 2007
Decided
May 16, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Original approval
P010012

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ACUITY SPIRAL LEAD MODEL 4591, 4592, AND 4593. THE DEVICE IS INDICATED FOR CHRONIC, LEFT-VENTRICULAR PACING AND SENSING VIA THE CORONARY VEINS WHEN USED IN CONJUNCTION WITH A COMPATIBLE PULSE GENERATOR.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.